Skip to main content
Clinical Trials/NCT06235762
NCT06235762
Completed
Not Applicable

Nutritional Intervention, Glycemic Control and Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus

Sao Jose do Rio Preto Medical School1 site in 1 country84 target enrollmentAugust 16, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes
Sponsor
Sao Jose do Rio Preto Medical School
Enrollment
84
Locations
1
Primary Endpoint
Body Mass Index (kg/m²).
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

The goal of this clinical trial is to evaluate the effects of nutritional intervention on anthropometric, biochemical and cardiovascular parameters in participants with type 2 diabetes mellitus. Participants will be distributed into 2 groups (control and intervention). Participants in the control group will only undergo conventional medical assessment and participants in the intervention group will receive the same medical care, concomitantly with nutritional assessment. The nutritional intervention is expected to reduce anthropometric data, glycemic and cardiovascular parameters in participants with T2DM, as opposed to the control group.

Detailed Description

The goal of this clinical trial is: 1- Evaluate the effects of nutritional intervention on anthropometric parameters {Weight, Body Mass Index (BMI), Waist Circumference and Waist Hip Ratio (WHR)}, biochemical parameters {Fasting blood glucose, Glycated Hemoglobin (HBA1C), Total Cholesterol ( TC), LDL Cholesterol (LDL-C), HDL Cholesterol (HDL-C) and Triglycerides} and cardiovascular {Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP) and Heart Rate (HR)}. 2- Evaluate behavioral patterns related to lifestyle, such as skipping breakfast, sleep quality (induction, maintenance and awakenings) and frequency of physical activity. 3-Support knowledge to the participant to build eating autonomy, consequently improving quality of life in the long term. This research will recruit participants diagnosed with T2DM (of both sexes aged between 18 and 80 years), at the Diabetes Outpatient Clinic and Hypertension at the Faculty of Medicine of São José do Rio Preto. The interventions will be distributed in quarterly meetings. Participants will be randomly distributed into 2 groups (control and the intervention group). The 40 participants in the control group will only undergo conventional medical evaluation and the 40 Participants in the intervention group will undergo the same medical care, concomitantly with nutritional assessment. Nutritional services will be made up of: A) Application of protocols (1-Nutritional History - Anthropometric, Biochemical and Clinical; 2-Habitual Food Record; 3-Sociodemographic protocol); B) Delivery of nutritional guidelines; C) Preparation of an individualized eating plan (inspired by the Mediterranean Diet and DASH diet with moderate carbohydrate content and restriction of saturated fats). It is expected that interventions modulate the recovery of nutritional status, dietary inadequacies, parameters anthropometric, biochemical, cardiovascular and clinics, thus improving quality of life and reducing the risk of events in participants with T2DM in long term. In this way, the participants in treatment with nutritional support will be able to achieve greater benefit, maximizing the construction of a process of autonomy to feed.

Registry
clinicaltrials.gov
Start Date
August 16, 2020
End Date
December 15, 2023
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Sao Jose do Rio Preto Medical School
Responsible Party
Principal Investigator
Principal Investigator

Tatiana Palotta Minari

Principal Investigator

Sao Jose do Rio Preto Medical School

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Body Mass Index (kg/m²).

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Body Mass Index (kg/m²) between the 0th and 12th month.

glycated hemoglobin (HBA1C) rates (%)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Glycated Hemoglobin (HBA1C) (%) between the 0th and 12th month.

Triglycerides concentration (mg/dl)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Triglycerides(mg/dl) between the 0th and 12th month.

Waist circumference (cm)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Waist circumference (cm) between the 0th and 12th month.

Total Cholesterol ( TC) concentration (mg/dl)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Total Cholesterol ( TC) (mg/dl) between the 0th and 12th month.

fasting blood glucose concentration (mg/dl)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Fasting blood glucose (mg/dl) between the 0th and 12th month.

Systolic Blood Pressure (SBP) (mmHg)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Systolic Blood Pressure (SBP) (mmHg) between the 0th and 12th month.

Diastolic Blood Pressure (DBP) (mmHg)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Diastolic Blood Pressure (DBP) (mmHg) between the 0th and 12th month.

Heart Rate (HR) beats per minute (bpm)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Diastolic Blood Pressure (DBP) (mmHg) between the 0th and 12th month.

Weight (kg)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on weight (kg) between the 0th and 12th month.

Waist Hip Ratio (WHR) [Waist circumference (cm)/hip circumference(cm)]

Time Frame: 12 months

Evaluate the impact of nutritional intervention on Waist Hip Ratio (WHR) between the 0th and 12th month.

LDL Cholesterol (LDL-C) concentration (mg/dl)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on LDL Cholesterol (LDL-C) (mg/dl) between the 0th and 12th month.

HDL Cholesterol (HDL-C) concentration (mg/dl)

Time Frame: 12 months

Evaluate the impact of nutritional intervention on HDL Cholesterol (HDL-C)(mg/dl) between the 0th and 12th month.

Secondary Outcomes

  • Sleep duration (hours) (more than 6 hours or less than 6 hours)(12 months)
  • Night awakenings (amount/ number)(12 months)
  • Skipping breakfast (yes or no)(12 months)
  • Physical activity level (sedentary, moderate, advanced)(12 months)

Study Sites (1)

Loading locations...

Similar Trials